Integrating vectors can lead to the dysregulation of nearby chromosomal genes, with important consequences for clinical trials and cellular engineering. This includes the retroviral and lentiviral vectors commonly used for deriving induced pluripotent stem cells (iPSCs). We previously used integrating foamy virus (FV) vectors expressing OCT4, SOX2, MYC and KLF4 to reprogram osteogenesis imperfecta mesenchymal stem cells (MSCs). Here, we have studied the effects of 10 FV vector proviruses on neighboring gene expression in four iPSC lines and their corresponding iPSC-derived MSC (iMSCs). Gene expression profiles in these iPSC lines showed that none of the 38 genes within 300 kb up-or downstream of integrated proviruses had a significant difference in mRNA levels, including five genes with proviruses in their transcription units. In the iMSCs derived from these iPSCs, the same type of analysis showed a single dysregulated transcript out of 46 genes found near proviruses. This frequency of dysregulation was similar to that of genes lacking nearby proviruses, so it may have been due to interclonal variation and/or measurement inaccuracies. While the number of integration sites examined in this paper is limited, our results suggest that integrated FV proviruses do not impact the expression of chromosomal genes in pluripotent human stem cells or their differentiated derivatives. This interpretation is consistent with previous reports that FV vectors have minimal genotoxicity, even when integrating near or within genes.
INTRODUCTION
Insertional mutagenesis due to vector integration is a major concern for gene and cell therapy. Integrated proviruses containing strong promoters and enhancers have the capacity to increase expression of nearby chromosomal genes, and activation of adjacent proto-oncogenes by gammaretroviral vectors can lead to clonal dominance and malignancies in human clinical trials. [1] [2] [3] [4] Changes in vector design such as long terminal repeat (LTR) deletions (self-inactivating or SIN vectors) that lack enhancer activity and the use of internal promoters have been developed and may improve safety. [5] [6] [7] Nevertheless, integration of SIN vectors still results in the dysregulation of adjacent genes in hematopoietic stem cells and induced pluripotent stem cells (iPSCs). 8, 9 SIN lentiviral (LV) vectors are less genotoxic than gammaretroviral vectors because in comparison they integrate away from transcription start sites and regulatory elements. [10] [11] [12] However, their integration within transcription units can still lead to dysregulation. 13, 14 In addition, it has been shown that the genotoxicity of SIN LV vector integration alone can give rise to iPSCs without reprogramming factors. 15 Foamy virus (FV) vectors are an alternative type of retroviral vector with a large packaging capacity, 16 wide host range, 17 and a complementary DNA genome. 18, 19 FV vectors may be less oncogenic than gammaretroviral and LV vectors because they do not preferentially integrate within genes or active transcription units, 20 have less transcriptional read-through activity, 21 and their deleted LTRs lack enhancer activity. 21 Also, the integration of FV vectors in canine hematopoietic stem cells did not lead to clonal expansion or malignancies after transplantation, 22 even when near proto-oncogenes. 23 While these studies suggest that FV vectors may have minimal genotoxicity, the effects of integrated FV vector proviruses on neighboring gene expression have not been determined previously.
We have shown that FV vectors can be used to reprogram mesenchymal stem cells (MSCs) with efficiencies similar to other vector systems, especially when the reprogramming genes were expressed from an internal Moloney murine leukemia virus (MLV) LTR promoter. 24 FV-derived iPSCs were pluripotent and could be differentiated into iPSC-derived MSC-like cells (iMSCs). Here, we examine the effects of these reprogramming vectors on chromosomal gene expression by determining their chromosomal locations and performing a global transcriptional analysis of FV-derived iPSC clones and their differentiated iMSC derivatives.
RESULTS AND DISCUSSION
Four independent iPSC lines were chosen for this study. iPSC clones c1, c2, c3 and c4 were derived by transducing bone marrow MSCs from osteogenesis imperfecta patients with the polycistronic FV reprogramming vector DF53MOSKMETNW, which expresses OCT4, SOX2, KLF4 and MYC as a single transcript separated by peptide cleavage signals under the control of an internal MLV LTR promoter ( Figure 1a ). These iPSC lines were shown to express pluripotency genes and had trilineage developmental potential by teratoma assays. 24 Cytogenetic analysis of two of these four iPSC lines showed that they had normal karyotypes. 24 Expression of the vector-encoded, polycistronic transgene cassette was assessed by reverse transcription PCR (RT-PCR) and quantitative RT-PCR and found to be absent in iPSC clones c2 and c3, at a low level in iPSC clone c1, and persistent in iPSC clone c4 (Figures 1b and d) . The MLV LTR promoter present in the vector is known to be frequently silenced in pluripotent cells. 25 Each iPSC clone was differentiated into iMSCs by embyroid body formation, plating on gelatin-coated dishes, and serial passaging in the presence of fetal bovine serum as described. 26 As reactivation of the viral transgenes can occur with differentiation, we evaluated the expression of the FV reprogramming cassette in these iMSC cultures, and observed reactivation in clones c1-c3, and persistent expression in c4 (Figures 1c and d) . These iMSCs expressed type I collagen and mesenchymal cell surface markers (Figures 1e and f), and formed bone in vitro and in vivo. 24 We identified a total of 10 FV integration sites in the four iPSC lines by southern blot analysis (Figures 2a and b ). Each of these was mapped unambiguously by inverse PCR (Figure 2c ) to a unique location in the human genome that agreed with the restriction digest fragment sizes observed on southern blots ( Table 1 ). Six of the integrants were located inside transcription units and four were outside of genes ( Figure 3 ). Two of these integrants were within 300 kb of the EPHA5 or ERBB4 protooncogenes associated with lung cancer 27 and multiple types of human tumors, [28] [29] [30] respectively. Overall, the 10 integrants were located within 300 kb of 46 different measurable transcripts. We determined the effects of FV proviruses on chromosomal gene expression by performing a global transcriptional analysis on undifferentiated cultures of iPSC clones c1, c3 and c4, as well as differentiated iMSC cultures of clones c1-c4 (undifferentiated iPSC clone c2 was not available for analysis). The Illumina Bead Chip v3 (San Diego, CA, USA) was used to measure the expression levels of 25 000 genes with 48 801 probes, and the levels obtained from each clone were compared with the average of the other clones for both undifferentiated iPSCs and differentiated iMSCs. The percentage of 42-fold up-or downregulated probe signals ranged from 0.02 to 0.51% between the iPSC clones and 0.17-0.68% between their iMSC cultures ( Table 2 ). These findings demonstrate that nearly 1% of all probe signals may vary 42-fold between clones of iPSCs or iMSCs, and this represents the background variation level in our expression profiles. We next evaluated the signal level of every microarray probe that detected a transcript located within a 300-kb window up-or downstream of an FV integration site. In the three iPSC clones studied, none of the 61 probes within this window had 42-fold signal differences when comparing cells that contained the nearby provirus to those lacking the provirus (Supplementary Figure 1 ). These iPSC data must be interpreted cautiously, as the reprogramming vectors were silenced or expressed at a low level in two of these clones (c1 and c3).
In the four iMSC cultures studied, all of which expressed the reprogramming vector transcript, one of 74 probes assayed (1.4%) had a 42-fold signal increase (threefold). This single probe detects the EBF1 transcript. In clone c3, integrant number 3 is 14 kb away from the EBF1 transcription start site and transcribed from the opposite strand ( Figure 3 ). Although this places the probe 415 kb from the integration site and outside the ± 300 kb window, it was included because it was the only probe that detected the EBF1 gene. We confirmed these microarray data by quantitative RT-PCR of EBF1 mRNA which showed a 5-, 12-and 210-fold increase in clone c3 iMSCs when compared with clone c2, c1 and c4 iMSCs, respectively. While it is possible that the enhancer activity of the internal MLV promoter increased EBF1 transcription, this observation may also have been unrelated to the provirus. The 1.4% of probes found near integration sites that were dysregulated ( Table 2) was not statistically different than the 0.45% percent of all probes dysregulated in iMSC c3 (Fisher's exact test, P-value ¼ 0.284). In addition, a power analysis showed that at least two neighboring probes would have to be dysregulated to achieve significance. This probe signal was also particularly inconsistent among iMSCs, as it varied 42-fold in the three iMSC cultures that lacked a nearby provirus.
Six of the proviruses we studied were located within the introns of transcription units, and none of these transcripts were dysregulated by provirus integration. In two cases, intronembedded proviruses were in the same orientation as the transcription unit, and the signals of downstream probes were still not significantly altered. These data confirm that FV vector proviruses do not result in read-through transcription, as suggested by prior transfection-based assays. 21 They also suggest that integration within an intron is not genotoxic, presumably due to splicing out of the vector provirus, as In summary, our analysis of 10 independent FV vector proviruses failed to demonstrate any dysregulation of nearby genes, although we cannot rule out that a larger sample size might have included a small percentage of dysregulated loci. Nevertheless, these results stand in contrast to those obtained with gammaretroviral and LV vectors, where dysregulation was noted in 3.2-20% or 3-13% of genes near integration sites, respectively. 14, [31] [32] [33] Also, a study analyzing only intragenic integration sites in LV-derived iPSC clones showed that 11% of these genes were dysregulated, 9 while in our study none of the genes containing FV vector proviruses were altered. Even when using SIN gammaretroviral and LV vectors, internal promoters with strong enhancer elements such as the MLV LTR increased the frequency of nearby gene dysregulation. 14 Notably, the FV vector used in our experiments contained the MLV promoter, but no dysregulation of nearby genes was observed. In addition, read-through transcription and aberrant splicing events from gammaretroviral and LV vectors can result in fusion transcripts that alter adjacent gene transcript levels, 13, 21, [34] [35] [36] [37] which we did not observe with FV vectors, suggesting that fusion transcripts were not produced at significant levels. In conclusion, we have found that FV vectors have minimal genotoxicity, supporting their use in gene therapy and cellular reprogramming. 
MATERIALS AND METHODS

Cell culture
Osteogenesis imperfecta MSCs were established from discarded bone fragments of affected individuals undergoing corrective surgery with Institutional Review Board approval. 38 Both MSCs and iMSCs were cultured in Dulbecco's modified Eagle's medium with low glucose containing 10% characterized fetal bovine serum (HyClone Laboratories, Logan, UT, USA), 100 U ml À 1 penicillin, 100 mg ml À 1 streptomycin and supplemented with 2 mM L-glutamine. Human iPSCs were cultured on irradiated mouse embryonic fibroblasts derived from the progeny of DR-4 mice 39 crossed with CF-1 mice (Charles River Laboratories, Wilmington, MA, USA) in Dulbecco's modified Eagle's medium/F12 medium supplemented with 20% Knockout Serum Replacement (Invitrogen, Grand Island, NY, USA), 1% nonessential amino-acid solution, 1% sodium pyruvate, 0.1 mM bmercaptoethanol, 100 U ml À 1 penicillin, 100 mg ml À 1 streptomycin and 2 ng ml À 1 basic fibroblast growth factor as described, 40 or on human embryonic stem cell-qualified matrigel (BD Biosciences, Bedford, MA, USA)
in TeSR 2 medium (StemCell Technologies, Vancouver, BC, Canada) when expanded for RNA analysis. iPSCs were derived from MSCs with the FV vector DF53MOSKMETNW as described previously, 24 where iPSC clones c1-c4 corresponded to iPSC clones iPSCe2-FVc1, iPSCe2-FVc2, iPSCe2-FVc3 and iPSCe2-FVc4. iMSCs were derived from iPSCs as described for human embryonic stem cells. 26 
Identification of FV integration sites
Genomic DNA was isolated from each iPSC line by using the Puregene DNA purification system (Gentra Systems, Minneapolis, MN, USA). Southern blot analysis and restriction digests were performed according to standard protocols. Radiolabeled probes were synthesized by random priming using Rediprime II (GE Healthcare, Piscataway, NJ, USA). For inverse PCR, 2 mg of genomic DNA was digested with eight units of Nla III, Hae III, Aci I, Hha I or Msp I restriction endonuclease (New England Biolabs, Beverly, MA, USA) at 37 1C for 2 h, extracted with phenol/chloroform, and precipitated with ethanol. Nucleic acid pellets were resuspended in 355 ml of water, 40 ml of 10 Â ligase buffer and 5 ml of T4 DNA ligase (New England Biolabs). Ligation reactions were incubated at 16 1C for 16 h. The ligase reactions were heatinactivated, extracted with phenol-chloroform, precipitated with ethanol and resuspended in 20 ml of 10mM Tris (pH 8.0), 1 mM EDTA. One microliter was used as template for PCR amplification with oligonucleotides ik213f (5 0 -GGGTGATTGCAATGCTTTCT) and ik214r (5 0 -TGTCTCTCATCCCAGGTACG) or ik224f (5 0 -AGCCTTGCTAAGGGAGACATCTAGTG) and ik225r (5 0 -GTTCTTCACCT CCTTCCCTGTA). DNA fragments were excised from agarose gels and cloned using the TA cloning vector pGEM T-easy (Promega, Madison, WI, USA). DNA sequences were obtained from these cloned PCR products.
Statistical analysis
Statistics were performed with JMP 9.0 statistical analysis software (SAS Institute Inc., Cary, NC, USA). Data was analyzed using the Fisher's exact test and two-sample proportions analysis. P-values o0.05 were considered statistically significant. For power analyses, statistical power was set at 0.8.
RT-PCR and gene expression analysis
RNA was isolated using an RNeasy kit (Qiagen, Valencia, CA, USA) according to the manufacturer's protocol from iMSCs or iPSCs grown on matrigel. Complementary DNA synthesis was performed from total RNA using the 
